A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma

M. A. Gertz, J. P. Garton, P. R. Greipp, T. E. Witzig, R. A. Kyle

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of high-dose methylprednisolone in refractory or relapsed multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences